January 8-10, 2018 - Biotech Showcase
Innovation meets money at Biotech Showcase exclusive investor event.
Kick off your business strategy during healthcare's most impactful week of the year.
Venue: HILTON SAN FRANCISCO UNION SQUARE, San Francisco, CA 94102 USA
For more information and to register: Biotech Showcase
January 8-11, 2018 - JP Morgan 36th Annual Healthcare Conference
Venue: San Francisco, CA, USA
February 12 - 13, 2018 - BIO CEO & Investor Conference
The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because the mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
Venue: New York Marriott Marquis, NY, USA
For more information and to register: BIO CEO & Investor Conference
February 22-25, 2018 - 58TH ANNUAL HEALTH LAW & LEGAL MEDICINE: THE OLD, THE NEW AND THE NOW
Dr. Jack Snyder, Managing Director at CATO Research Washington, and Co-Director of Pharmacovigilance for Cato Research Ltd., will offer two presentations. The first presentation is entitled "Daubert v. Merrell Dow Pharmaceuticals: A 25-Year History". The second presentation is entitled "An Update on FDA's Risk Evaluation and Mitigation Strategy (REMS) Initiatives".
Venue: FRANCIS MARION HOTEL, Charleston, South Carolina, USA
For more information and to register: 58TH ANNUAL HEALTH LAW & LEGAL MEDICINE: THE OLD, THE NEW AND THE NOW
February 28, 2018 & March 1, 2018 - Biocom's Global Life Science Partnering Conference
Biocom's 8th Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies.
Venue: 11480 North Torrey Pines Road, La Jolla, California, USA
For more information and to register: Biocom's Global Life Science Partnering Conference
March 12-14, 2018 - BIO-Europe Spring
With a focus on European innovation and global collaboration, BIO-Europe Spring is the premier springtime partnering conference bringing together a "whoʼs who" from biotech, pharma and finance in the most innovative biopharma clusters in Europe.
Venue: Amsterdam RAI Convention Center, Amsterdam, The Netherlands
For more information and to register: BIO-Europe Spring
March 20-21, 2018 - Outsourcing in Clinical Trials Israel 2018
Cato Research is Sponsoring and Exhibiting - Stop by and visit with us at Booth #15:
Arena International is thrilled to announce that the fourth Outsourcing in Clinical Trials conference is returning to Tel Aviv, 20th – 21st March 2018; the only clinical outsourcing platform for biotech, pharmaceutical and medical device companies within Israel.
As with its reputation, this conference addresses how companies can effectively develop their outsourcing strategies and attendees will attain an increased understanding of how to enhance their operational efficiencies to ensure timely and cost-effective clinical studies.
Venue: Tel Aviv, Israel
For more information and to register: Outsourcing in Clinical Trials Israel 2018
April 16-17, 2018 - LORENZlink 2018 RIM Solutions Conference
Interact with industry and agency professionals on regulatory topics like:
- RIM Technology: Understanding Process Development
Sandra Krogulski, Accenture Accelerated R&D Services
- Key Success Factors in Approaching eTMF from Start to Finish
Maria Crump, Regulatory Professionals, Inc
- Update on Electronic Submissions at Health Canada
Irena Pastorekova, Health Canada
- Successful AdPromo Launch submitted in eCTD Format
Teresa Martins, Bayer
- Harmonizing Submission Publishing Across Three Sites at Emergent Biosolutions
Christopher Leonienco, Emergent Biosolutions
Venue: Gaylord Opryland Resort, Nashville, TN, United States
Meet with our Team!Send Us a Request to Meet
April 18, 2018 - Join Cato Research for a Celebratory Wine Tasting - Pioneering Drug Development Pathways for 30 Years!
Join CATO in our Durham office as we celebrate 30 years of pioneering drug development pathways!
Wednesday, April 18th, 5 - 7:30 pm at Cato Research Durham, 4364 South Alston Avenue, Durham, NC 27713, Phone: +1 (919) 361-2286
Enjoy an evening of fine wines highly rated by the Wine Advocate or the Wine Spectator, accompanied by delectable hors d'oeuvres.
For more information and to register: Join Cato Research for a Celebratory Wine Tasting
April 21, 2018 - Cato Research and Cancer Advances Proud Sponsor of PurpleStride: Raleigh-Durham 2018 5K RUN & Family-Friendly Walk for Pancreatic Cancer Awareness and Research
Wage Hope at PurpleStride. The Walk to end pancreatic cancer.
Join Cancer Advances Team and Cato Research for PurpleStride Raleigh-Durham to help us make strides against pancreatic cancer. Enjoy a day filled with children's activities, music, refreshments, the Shop Purple store, and more!
PurpleStride is the signature event of the Pancreatic Cancer Action Network. Each year, in communities across the country, tens of thousands of people participate in more than fifty-six PurpleStride events, including PurpleStride Raleigh-Durham. These events are critical in raising awareness and funds that advance research and support patients and loved ones with a promise of a better tomorrow.
The Pancreatic Cancer Action Network is blazing new trails in the fight against pancreatic cancer. Join us for PurpleStride Raleigh-Durham and together we will continue to rewrite the book on how to fight this deadly disease.
Venue: North Carolina State University - Centennial Campus Oval, North Carolina, Raleigh USA
For more information and to contribute or participate: Cato Research and Cancer Advances Proud Sponsor of PurpleStride: Raleigh-Durham 2018 5K RUN & Family-Friendly Walk for Pancreatic Cancer Awareness and Research
May 15-17, 2018 - Israeli MIXiii BIOMED Conference
Cato Research is Sponsoring and Exhibiting - Come Visit Us at Booth #29!
This year, MIXiii-BIOMED will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life sciences.
As we envision and analyze our projections for the future of healthcare systems, we should address and asses ways to diagnose and treat patients by utilizing next generation methods with emphasize on regenerative medicine and cell therapies. With the goal of improving the way we treat, prevent and cure diseases, we should consider innovations in precision and targeted medicine genetics, personal diagnosis, treatment and monitoring.
Venue: David InterContinental Hotel, Tel Aviv, Israel
Meet with our Team! Send Us a Request to Meet
June 1-5, 2018 - ASCO Annual Meeting
The Annual Meeting brings together oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.
Venue: McCormick Place, Chicago, ILMeet with our Team! Send Us a Request to Meet
June 2-5, 2018 - Digestive Disease Week® (DDW)
Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world's largest gathering of physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Venue: Walter E. Washington Convention Center, Washington, DCMeet with our Team! Send Us a Request to Meet
June 4, 2018 - RESI Boston
Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great ROI for cost conscious CEOs.Meet with our Team!Send Us a Request to Meet
June 4-7, 2018 - BIO International
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
Venue: Boston, MAMeet with our Team! Send Us a Request to Meet
June 12, 2018 - NCBIO's Legislative Reception
More than 150 life science company representatives and legislators will meet for an evening reception highlighting North Carolina's life sciences industry.
Venue: NC Museum of History, Raleigh, NC, USAMeet with our Team! Send Us a Request to Meet
April 21, 2018
Cato Research Cancer Advances Proudly Sponsors PurpleStride Raleigh-Durham 2018
March 23, 2018
Cato Research awarded "Best International Clinical Trial Services Provider 2018"
Lynda Sutton, principle and cofounder of Cato BioVentures, a family owned venture capital of Cato Holdings, was recently featured in BioWorld's article titled, "Alternative to traditional venture capital money could fill translational gaps" by Jennifer Boggs, for her panel discussion at this year's January RESI conference featuring Cato BioVentures' innovative investment approaches in the healthcare sector:
"Cato Bioventures, for instance, started investing in gene therapy in 2000. "We're finally seeing early results," said Lynda Sutton, principal and co-founder.
Launched in 1988 as the venture capital affiliate of Cato Holding, a privately held family fund, has built a portfolio of firms, including those developing therapeutics, medical devices and stem cell therapies. It invests in firms at all stages of development and across multiple therapeutic areas, and its funds have gone into both public and private firms. Cato Bioventures offers a two-pronged approach to its investments, said Sutton, who, like de Souza, is another pharma veteran. The first is to look for technology "that needs a home, bring it in and form a company around it," with the aim of getting it to a value inflection point. The second involves looking for companies with good management, promising technology and invest money and resources to complement drug development efforts."
October 2, 2017
Mallinckrodt plc (NYSE:MNK) today announced it has entered into a licensing agreement for development and commercialization of NeuroproteXeon's investigational, pharmaceutical-grade xenon gas for inhalation therapy being evaluated to improve survival and functional outcomes for patients resuscitated after a cardiac arrest.
April 29, 2017
Cato Research and Cancer Advances Proudly Sponsors PurpleStride Raleigh-Durham 2017
May 10, 2016
Cancer Advances Proudly Sponsors PurpleStride Raleigh-Durham 2016
May 05, 2016
Manufacturing has begun for Cancer Advances' Lead Product
March 28, 2016
NeuroproteXeon Appoints Cato Research for Phase III Trials
NeuroproteXeon Appoints Cato Research for Phase III Trials
Mervyn Maze, MB, ChB, Chief Medical Officer of NeuroproteXeon announced CATO Research of Durham, North Carolina as the Clinical Research Organization (CRO) administering the Company’s Phase III trial. Dr. Maze indicated the selection reflects CATO’s three decades of experience in international trial administration, their broad international scope, and the ease with which NP and CATO management interacted.
Present plans are for a nine country, approximately 30 sites, 1,300 patent trial, comparing hypothermia with hypothermia plus Xenon. The primary outcome will be survival from cardiac arrest. It is anticipated the trial will be complete in less than two years following FDA/ EMA approval of the Company’s IND application.
March 8, 2016
Cancer Advances attends PanCAN
November 2, 2015
Cato BioVentures at BIO-Europe in Munich, Germany
October 28, 2015
Cancer Advances Announces $48.5 Million Funding Commitment
June 15, 2015
Join Cato BioVentures at 2015 BIO International Convention
May 15, 2015
Cancer Advances and Cato Research to Participate PurpleStride: Raleigh-Durham 2015 5K RUN & Family-Friendly Walk for Pancreatic Cancer Awareness and Research
January 15, 2015
Cancer Advances to attend ASCO Gastrointestinal Cancers Symposium
© 2017 Cato Research. All rights reserved.